PSMA-11
Showing 1 - 25 of 3,674
Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)
Recruiting
- Prostate Cancer
- PET/CT
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of China University of Science and
Jul 19, 2023
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy
Enrolling by invitation
- Castration-Resistant Prostate Carcinoma
- +2 more
- Computed Tomography
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Glioma, Malignant, Glioma Glioblastoma Multiforme Trial in Warsaw ([68Ga]Ga-PSMA-11 PET/CT)
Completed
- Glioma, Malignant
- Glioma Glioblastoma Multiforme
- [68Ga]Ga-PSMA-11 PET/CT
-
Warsaw, Mazowieckie, PolandNuclear Medicne Department Medical University of Warsaw
May 29, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Columbia (Ga-68-PSMA-11)
Terminated
- Prostate Cancer
- Prostate Adenocarcinoma
-
Columbia, MissouriTruman VA Hospital
Feb 15, 2023
Biochemically Recurrent Prostate Carcinoma Trial in Duarte (Gallium Ga 68-labeled PSMA-11, Positron Emission Tomography)
Suspended
- Biochemically Recurrent Prostate Carcinoma
- Gallium Ga 68-labeled PSMA-11
- Positron Emission Tomography
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 12, 2022
Hepatocellular Carcinoma Trial in Rochester (Gallium Ga 68 Gozetotide, Hepatic Artery Embolization, Positron Emission Tomography
Recruiting
- Hepatocellular Carcinoma
- Gallium Ga 68 Gozetotide
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 11, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Prostate Cancer Trial in Beijing (68Ga-P16-093, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Nov 1, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Patients With Metastatic Castration-resistant Prostate Cancer Trial (177Lu-PSMA-617 PET scan)
Not yet recruiting
- Patients With Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA-617 PET scan
- (no location specified)
Nov 13, 2023
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer American Joint Committee on
Terminated
- Castration-Resistant Prostate Carcinoma
- +4 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 19, 2022
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,
Not yet recruiting
- Prostate Adenocarcinoma
- +3 more
- Apalutamide
- +7 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023
Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)
Recruiting
- Prostate Cancer Metastatic
-
Peking, ChinaPeking Union Medical College Hospital
Nov 25, 2022
Prostate Cancer Trial in Bern (18F-PSMA-1007, 68Ga-PSMA-11)
Recruiting
- Prostate Cancer
- 18F-PSMA-1007
- 68Ga-PSMA-11
-
Bern, SwitzerlandInselspital, Universitätsspital Bern
Jul 4, 2022
Prostate Cancer Trial (Radiopharmaceutical 68Ga-PSMA-11 PET/CT)
Not yet recruiting
- Prostate Cancer
- Radiopharmaceutical 68Ga-PSMA-11 PET/CT
- (no location specified)
Oct 12, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Aurora, Denver (Ga-PSMA-11)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Aurora, Colorado
- +1 more
Jul 28, 2022
Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,
Not yet recruiting
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- +2 more
- 68Ga-PSMA-11
- PET/CT or PET/MRI
-
Changsha, China
- +5 more
Apr 26, 2023
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Houston (Computed
Not yet recruiting
- Metastatic Prostate Carcinoma
- +4 more
- Computed Tomography
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)
Active, not recruiting
- Prostate Cancer
- High Risk
-
Houston, TexasHouston Methodist
Dec 8, 2022
Malignant Brain Tumors Trial in Berkel en Rodenrijs (procedure, device, other)
Recruiting
- Malignant Brain Tumors
- intra-arterial injection
- +2 more
-
Berkel en Rodenrijs, Zuid Holland, NetherlandsLaurens Groenendijk
Apr 3, 2023
Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission
Available
- Prostate Cancer
- +2 more
- 68Ga-PSMA-11
- Positron Emission Tomography/Computed Tomography
-
Dallas, TexasUT Southwestern Medical Center
Sep 27, 2022
Biochemically Recurrent Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +6 more
- Computed Tomography
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 7, 2022